Standout Papers

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine ch... 2001 2026 2009 2017 546
  1. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. (2002)
    Reginald V. Lord, Jan Brabender et al. PubMed
  2. ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy (2001)
    Yoshinori Shirota, Jan Stoehlmacher et al. Journal of Clinical Oncology

Immediate Impact

3 by Nobel laureates 24 from Science/Nature 74 standout
Sub-graph 1 of 19

Citing Papers

Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
2023 Standout
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
7 intermediate papers

Works of Jan Brabender being referenced

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.
2002 Standout
Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.
2001
and 3 more

Author Peers

Author Last Decade Papers Cites
Jan Brabender 1317 1729 2019 1898 100 4.5k
Markus Borner 1117 1806 1765 2945 125 5.4k
Helmut E. Gabbert 1548 1646 2717 2198 126 6.1k
Dongfeng Tan 764 886 1846 1577 122 3.9k
Shoji Natsugoe 1582 1404 2013 2446 195 5.5k
P. V. Danenberg 825 1507 2476 3416 76 5.3k
Georg Lurje 1640 1104 1204 1943 157 4.5k
Dipok Kumar Dhar 2203 1438 1559 1054 126 5.3k
Davide Melisi 1565 1242 2373 3347 158 5.7k
Francesco Graziano 1280 1746 1779 3260 162 5.7k
Gennaro Galizia 1292 1879 1161 2754 139 5.1k

All Works

Loading papers...

Rankless by CCL
2026